Andrew Hyland

Ph.D.

Principal Investigator, ITC Four Country, USA
Roswell Park Comprehensive Cancer Center, University of Buffalo, USA

Andrew Hyland, Ph.D., is the Chair of the Department of Health Behavior at Roswell Park Cancer Institute, and he also directs the Survey Research and Data Acquisition Resource at Roswell Park.  He holds a Ph.D. in Epidemiology and a M.A. in Statistics from the State University of New York at Buffalo.

Dr. Hyland’s primary research interests lie in evaluating the impact of policies aimed at reducing the morbidity and mortality associated with the use of tobacco products. He is the principal investigator on numerous peer review grants and contracts. Dr. Hyland is the scientific leader of the Population Assessment of Tobacco and Health study (PATH), which is supported by the National Institute on Drug Abuse and the Food and Drug Administration to study nearly 45,000 adults and children to understand changes in tobacco use patterns and health outcomes over time.

Institution Profile: https://www.roswellpark.org/andrew-hyland
Institution Link: https://www.roswellpark.org/